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Abstract
Background: The two-component systems of Mycobacterium tuberculosis are apparently required for its growth
and resistance in hostile host environments. In such environments, MtrAB has been reported to regulate the
expression of the M. tuberculosis replication initiator gene, dnaA. However, the dnaA promoter binding sites and
many potential target genes for MtrA have yet to be precisely characterized.
Results: In this study, a 7 bp sequence motif in the dnaA promoter region was identified for MtrA binding using
DNaseI footprinting assays and surface plasmon resonance (SPR) analysis. Approximately 420 target genes
potentially regulated by MtrA, including the isoniazid inducible gene iniB, were further characterized from
M. tuberculosis and M. smegmatis genomes. When assayed using quantitative real-time PCR (qRT-PCR), many of the
target genes demonstrated significant expression changes when the antisense mRNA of the mtrA gene was
expressed in M. smegmatis. The recombinant mycobacteria grew in length and were more sensitive to two anti-
tuberculosis drugs, isoniazid and streptomycin.
Conclusions: These findings yield critical information about the regulatory mechanisms of the MtrAB two-
component system and its role in the drug resistance of M. smegmatis.
Background
M. tuberculosis is one of the most devastating human
pathogens, and its threat to human health has intensi-
fied with the emergence of multidrug-resistant tubercu-
losis (TB) and the worldwide prevalence of co-infection
with HIV [1,2]. Two-component regulatory systems
(TCRs) are widely distributed among bacteria and plants
and enable organisms to regulate gene expression in
response to a variety of environmental stimuli [3,4].
Some TCRs are clearly involved in regulating the viru-
lence of pathogenic bacteria [3].
The M. tuberculosis genome contains 11 paired TCRs
and several orphan kinases and regulators [5]. Several
TCRs are apparently required for the growth of
M. tuberculosis under specific conditions [6-8]; for
example, mprA-mprB is important for the maintenance
of persistence [6]. Of the 11 M. tuberculosis TCRs, only
the mtrA-mtrB system has been confirmed as essential
for in vitro and in vivo survival of M. tuberculosis
[9-11]. Several recent reports show that the regulator
MtrA modulates M. tuberculosis proliferation by regulat-
ing dnaA expression and binding the origin of replica-
tion [12,13]. In Mycobacterium avium,m o r p h o t y p i c
multidrug resistance requires the presence of an MtrA
homologue [14].
The mtrAB system has been successfully deleted in
Corynebacterium glutamicum, an industrial amino acid
production strain [15]. Mutant cells lacking mtrAB
showed a different cell morphology and were more sen-
sitive to penicillin, vancomycin, and lysozyme, however,
they were more resistant to ethambutol [15]. The
expression of some genes involved in both peptidogly-
can metabolism and osmoprotection was also substan-
tially changed [15]. Therefore, MtrAB in C. glutamicum
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lism and osmoprotection.
The M. tuberculosis MtrAB system is thought to be
involved in the expression of many target genes and
contributes to the pathogen survival and resistance
within its host tissue. However, these target genes and
their MtrA binding sites have not been clearly estab-
lished. In the current study, we have identified con-
served sites for the recognition of MtrA in the dnaA
promoter, as well as approximately 420 potential target
genes. Further in vivo studies concerning a related
organism, M. smegmatis, reveal changes in both cell
morphology and drug resistance when MtrA gene
expression is inhibited. The data presented here signifi-
cantly enhance our understanding of the regulatory
mechanisms of the essential two-component MtrAB
system and its role in mycobacterial drug resistance.
Results
MtrA interacted with the regulatory region of the M.
tuberculosis dnaA gene
Bacterial one-hybrid assays confirmed the interaction
between MtrA and the regulatory sequence of the dnaA
initiator gene. The dnaA promoter region was cloned
into the reporter genes upstream of HIS3-aadA and the
reporter vector pBXcmT (Fig. 1A). As shown in Fig. 1B,
the co-transformant strain with the dnaA promoter and
MtrA was observed to grow well on the screening med-
ium. In contrast, there was no growth for the strain
containing either MtrA or the dnaA promoter alone. In
addition, neither the co-transformant strain containing
an unrelated DNA, SsoDNA (Additional file 1), nor
MtrA did grew, indicating that this DNA cannot interact
with MtrA (Fig. 1B). Thus, MtrA specifically interacted
with the dnaA gene promoter.
The interaction of the purified MtrA protein with the
dnaA promoter was confirmed by the interaction with
the DNA on the chip. As shown in Fig. 1C, the biotiny-
lated promoter DNA was first associated with the strep-
tavidin (SA) chip (GE Healthcare). When an increasing
concentration of MtrA protein (100-500 nM) was passed
over the chip surface, a corresponding increasing
response value was observed. This again indicated that
the MtrA protein could bind with the dnaA promoter
DNA (Fig. 1C). In contrast, heated inactive protein
showed no response when it was passed over the chip
( F i g .1 C ) .W h e na nu n s p e c i f i cD N A ,t h ep r o m o t e ro f
Rv0467, was coated on the chip, no significant associa-
tion for MtrA was observed (Additional file 2). In a
further confirmatory experiment, 200 μM unlabeled pro-
moter DNA was also added along with the MtrA pro-
tein. This DNA competed with that on the chip for the
available MtrA; here, a significantly lower response was
observed compared to a control with no competition
(Fig. 1D).
Characterization of the DNA-box motif in the dnaA
promoter that allows MtrA binding
Several short DNA fragments (S1-S5) were used to pre-
cisely determine the DNA-box motif for the MtrA in
this promoter region (Fig. 2A). As shown in Fig. 2B, a
specific protein/DNA complex was observed on S1, S2,
and S5, indicating that MtrA could recognize these
DNA substrates. In contrast, no binding activity was
observed for substrates S3 and S4, both of which lacked
the 5-CACGCCG-3 or 5-CACGAGG-3 sequence box
(Fig. 2A). Further confirmation of the specific interac-
tion was obtained by conducting the competing surface
plasmon resonance (SPR) assay with the unlabeled DNA
fragments. As shown in Additional file 3, a significantly
lower response was observed when either the unlabeled
S2 or S5 was added together with MtrA, which indi-
cated that they could compete the binding of MtrA with
the promoter DNA on the chip. Therefore, these two
sequence motifs appeared to be essential for the MtrA
binding with the dnaA regulatory region.
The interaction between MtrA and these two
sequence boxes was further confirmed by DNase I foot-
printing assays (Fig. 3). Regions that contain these two
boxes were significantly protected when MtrA was pre-
sent. Protection at S6 occurred at all MtrA concentra-
tions while the protection of S7 was dependent on the
concentration of MtrA. This suggests that MtrA has
different binding affinities with these regions.
We characterized two sequence boxes for the recogni-
tion of MtrA within the dnaA promoter, situated imme-
diately downstream of promoters P1 and P2. The
binding sequence boxes and their situation within the
dnaA promoter are summarized in Fig. 2C.
Characterization of potential target genes regulated by
MtrA in mycobacterial genomes
We searched the intergenic regions of the M. tuberculosis
and M. smegmatis genomes extensively based on the two
sequence motifs for MtrA in the dnaA gene promoter
region. To validate the target genes, several regulatory
r e g i o n so ft h eg e n e sw e r ea m p l i f i e d .T h eD N A - b i n d i n g
activities of MtrA were examined using EMSA assays. As
shown in Fig. 4, the regulatory sequence of a predicted
target gene, isoniazid inducible gene iniB (rv0341), could
be recognized by MtrA. A specific DNA/protein complex
band was also observed. In addition, MtrA was able to
bind with two target promoter DNA sequences of
Rv0574 (a hypothetical protein) and Rv3476 (KgtP), pro-
ducing a corresponding DNA/protein band (Fig. 4A).
The positive target DNA was shown to bind with MtrA,
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motif could also be found in the promoter regions of two
previously characterized target genes, CgmepA and
CgproP,i nC. glutamicum.I n t e r e s t i n g l y ,M. tuberculosis
MtrA bound with the regulatory sequences and produced
specific shifted bands (Fig. 4A).
A further logo assay for the consensus sequence was
conducted using the WebLogo tool [16]. A more general
conserved motif for MtrA recognition was mapped out
(Fig. 4B). In all, 155 potential target genes were charac-
terized from the M. tuberculosis genome (Additional file
4), and 264 genes were characterized from the M. smeg-
matis genome (Additional file 5).
Effects of mtrA gene expression level on mycobacterial
drug resistance and cell morphology
The mRNA antisense expression of the mtrA gene in
M. smegmatis showed a regulatory effect of mtrA on
mycobacterial drug resistance and cell morphology [17].
No substantial change was observed for the general
growth of the recombinant mycobacterial strains. How-
ever, as shown in Fig. 5A, the recombinant mycobacterial
Figure 1 Two-component regulator MtrA interacts with the regulatory region of dnaA. (A) The regulatory sequence of the dnaA initiator
gene was cloned into the reporter genes upstream of HIS3-aadA of the reporter vector pBXcmT (24). (B) The interaction between MtrA and the
promoter region of dnaA was measured by bacterial one-hybrid analysis. Upper panel: bacterial two-hybrid plates. Lower panel: an outline of the
plates in the upper panel. Each unit represents the corresponding co-transformant in the plates. CK
+: co-transformant containing pBX-Rv2031p
and pTRG-Rv3133c as a positive control (24). CK
-: co-transformant containing pBX-Rv2031p and pTRG-Rv3133c-deltaC as a negative control (24).
SsoDNA, an unrelated archaeal DNA sequence, was also used a negative control. (C) SPR assays for the binding of dnaA promoter chip by MtrA.
(D) The specific interaction between the regulatory region of the M. tuberculosis dnaA gene was assayed by SPR. Unlabeled promoter DNA was
used as competition for the binding of MtrA with DNA on chip. An overlay plot was produced to show the interactions.
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streptomycin, as evidenced by their inhibited growth in
t h ep r e s e n c eo f2 5μg/mL of isoniazid or 0.5 μg/mL of
streptomycin in the medium. In contrast, no noticeable
inhibition was observed for two other drugs, ethambutol
and rifampicinB (data not shown). With a general growth
of the recombinant mycobacterial strains resulting
in minimal change, the cell morphology was further
examined using the scanning electron microscopy (SEM)
technique. As shown in Fig. 5B, the cell lengthened when
20 ng/mL tetracycline was added to the medium to
induce expression of the antisense mtrA mRNA (right
panel).
When relative gene expression was measured via qRT-
PCR as shown in Fig. 5C, the mtrA gene was only
0.38-fold that of the wild-type strain, indicating that the
expression of the mtrA gene in recombinant M. smeg-
matis was greatly inhibited. The expression of the dnaA
gene in the recombinant strain basically remained con-
s t a n tw h e nc o m p a r e dw i t ht h a ti nt h ew i l d - t y p es t r a i n .
This was consistent with the fact that no conserved
sequence motif existed within the regulatory region of
this gene in M. smegmatis. Another approximately 26
potential target genes were randomly chosen to measure
the expression change in the recombinant M. smegmatis
strain (Fig. 5C). The expression levels of these genes
Figure 2 Characterization of the sequence motifs for MtrA in the M. tuberculosis dnaA gene promoter region. The DNA-binding assays
of M. tuberculosis MtrA were performed using modified EMSA and SPR assays, as described in “Materials and Methods”. (A) Several short DNA
fragments were synthesized and used as DNA substrates, which covered a different dnaA gene promoter region. The sequences of their positive
strands are indicated, and two 7 bp motifs are underlined. (B) The DNA-binding assays for MtrA on different DNA substrates. The EMSA reactions
(10 μl) for measuring the mobility shift contained 200 fmol
32P-labeled DNA and increasing amounts of MtrA proteins (100 nM-600 nM). The
protein/DNA complex is indicated by arrows on the right of the panels. (C) Schematic representation of conserved motifs located downstream
of two dnaA promoters. The base-pair numbers far from the start codon of the dnaA gene are indicated.
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increased 2.5-fold expression (Fig. 5C), while mraZ
(Msmeg_4236) and rpfB (Msmeg_5439) gene expression
decreased by about 0.2-fold (Fig. 5C).
Therefore, the inhibition of the mtrA gene resulted in
corresponding expression changes in many predicted
target genes in M. smegmatis. The expression level of
the mtrA gene consequently affected the drug resistance
and cell morphology of M. smegmatis.
Discussion
MtrAB has been reported to regulate the expression of
the M. tuberculosis replication initiator gene, dnaA [12].
However, potential binding sites for MtrA have not
been clearly characterized. In addition, there are many
potential target genes that also appear to be regulated
by MtrA. In the current study, we identified a 7 bp con-
served sequence motif for the recognition of MtrA
within the dnaA promoter. About 420 potential target
genes regulated by MtrAB were predicted from the
M. tuberculosis and M. smegmatis genomes upon
searching their promoter databases. Many predicted tar-
get genes showed significant expression changes when
the mtrA homologue of M. smegmatis was partially
inhibited. The recombinant M. smegmatis cells increased
in length and became sensitive to the anti-TB drugs
isoniazid and streptomycin.
The transcription of dnaA starts essentially at P1dnaA,
which is conserved in all mycobacterial species [18].
The analysis of the sequence in the upstream region of
dnaA revealed a second promoter, P2dnaA, in M. tuber-
culosis [18]. In previous in vivo experiments, MtrA
bound with the regulatory region of the dnaA gene [12].
In the current study, two binding motifs for MtrA were
located immediately downstream from the two promo-
ters (Fig. 2C). Therefore, MtrA can apparently interfere
with the promoter activity and thus regulate the expres-
sion of the replication initiator gene. The promoter
P2dnaA only exists in a viral strain or derivative strains
such as M. tuberculosis, M. bovis and BCG, but not in
M. avium or M. smegmatis [18]. This suggests that the
two-component system MtrAB might contribute to the
virulence of the M. tuberculosis complex through selec-
tive regulation of dnaA gene expression. A parallel
study [13] has identified a “GTCACAgcg” motif for the
recognition of MtrA in the fbpB promoter and the ori-
gin of replication. Interestingly, there exists a common
conserved core sequence between the 9 bp motif and
Figure 3 MtrA footprinting analysis in the M. tuberculosis dnaA promoter region. (A) DNase I footprinting assay of the protection of two
short dnaA promoter regions (S6 and S7) against DNase I digestion by MtrA. The substrate S6 contains S1 and S2 sequences, and the substrate
S7 contains S5 sequences. The ladders are shown in the right panel and the obtained nucleotide sequences are listed. The protected regions are
indicated. The two specific sequence boxes are indicated by “*”. (B) Summary of MtrA footprinting analysis in the M. tuberculosis dnaA promoter
region. The DNA sequence correspond with the dnaA promoter region from -303 to -1. The position of two transcription start sites (P1dnaA and
P2dnaA), two footprint regions, and two MtrA binding boxes are indicated.
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current study. Using a MalE-EnvZ kinase, but not the
cognate partner kinase of MtrB, Rajagopalan et al sug-
gested that the phosphorylation of MtrA had distinct
regulation capacities. However, only 5% of the MtrA
p r o t e i nw a ss h o w nt ob ep h o s p h o r y l a t e d[ 1 3 ] .I nt h e
present study, efforts to phosphorylate MtrA using the
partner kinase of MtrB failed (data not shown). Impor-
tantly, using several different methods, we showed that
the nonphosphorylated MtrA could bind to the target
DNA very well, suggesting that the form of MtrA might
be involved in regulating the expression of its target
genes. Obviously, the regulation mechanism of MtrAB
needs to be further addressed in the future.
Attempts to disrupt the mtrA gene in M. tuberculosis
have been unsuccessful; thus, mtrA seems to be an essen-
tial gene for M. tuberculosis proliferation [11]. The genes
encoding the MtrAB two-component system of C. gluta-
micum were deleted successfully, and this deletion
strongly influenced the cell morphology, antibiotic sus-
ceptibility, and expression of genes involved in osmopro-
tection [15]. In the current study, a large group of target
genes for MtrA was characterized from the genomes of
both M. tuberculosis and M. smegmatis, including multi-
ple transcriptional factors such as TetR family regulators,
stress gene family protein (MSMEG_3308), and the iso-
niazid inducible protein IniA (MSMEG_0695). Inhibition
of the mtrA gene, therefore, resulted in corresponding
Figure 4 Characterization of the conserved sequence motif for MtrA in mycobacteria and C. glutamicum. (A) EMSA assays for validating
the binding of MtrA with regulatory sequences of several potential target genes from M. tuberculosis. The promoter DNA of M. tuberculosis dnaA
gene was used as positive control. An unrelated DNA was used as negative control. Several DNA substrates, namely, Rv0341_up, Rv0574c_up, and
Rv3476c_up, were amplified from their promoter regions using specific primers. Several regulatory sequences of potential target genes from C.
glutamicum including CglumepAp and CgluproPp, were amplified and used as DNA substrates. (B) A blast assay for the conserved sequence motif
recognition by MtrA. Sequence alignment was carried and visualized by local BioEdit software. The complete consensus sequence is indicated by
the stars under the base in the upper panel. Sequence logo was generated by WebLogo tool.
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M. smegmatis (Fig. 5C).
In the current study, we found the conserved motifs of
the MtrAB two-component system upstream of a large
list of genes that have several different functions, includ-
ing cell cycle progression regulation, secreted antigen,
and drug resistance. Interestingly, as shown in Addi-
tional file 6, there are 42 genes (10%) that were found in
both mycobacterial species. MtrA was reported to be
involved in the transcriptional regulation of dnaA in
M. tuberculosis; this provides the first direct evidence of
its role in cell cycle progression [12]. In M. avium,
MtrAB could respond to general stresses and ultimately
inhibit cell division [14]. A recent study found that the
promoter for immunodominant secreted antigen 85B
was also characterized as the targets of MtrA [13].
Therefore, our findings were consistent with these pre-
vious studies.
Among the many predicted target genes, there are
drug resistance and transport-related genes (including
Figure 5 Effects of the expression level of mtrA gene on target genes and cell growth in M. smegmatis. (A) Drug resistance assays. The
antimicrobial activity of four first-line anti-tuberculosis drugs against M. smegmatis was determined as described under “Materials and Methods”.
Representative growth curves for isonizid and streptomycin are shown. (B) Scanning electron microscopy assay of cell morphology. The
experiment was carried out as described in the “Materials and Methods”. Representative images are shown. The images were taken at 15,000×
magnification. Bars, 1 μm. (C) qRT-PCR assays for the gene expression of M. smegmatis. The experiment was carried out as described in the
“Materials and Methods”. 16S rRNA gene, rrs, was used as control. All target genes were amplified using specific primers. Different gene
expressions were normalized to the levels of 16S rRNA gene transcripts, and the folds of expression change were calculated. Representative data
are shown.
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integral membrane gene, and osmoprotection-related
genes. The operon iniBAC was previously found to con-
fer multidrug tolerance to M. bovis BCG through an
associated pump-like activity, and was induced by iso-
niazid and ethambutol [19,20]. These findings suggest
that the mtrA gene might be involved in drug resistance.
In the current study, we have confirmed that MtrA
c o u l db i n dt h einiB promoter region. The recombinant
M. smegmatis strain was found to become sensitive to
the anti-TB drugs, isoniazid and streptomycin, when
mtrA gene expression was inhibited by an antisense
mRNA technique (Fig. 5A). In M. avium, mtrAB was
shown to play a role in regulating the composition and
permeability of mycobacterial cell walls and was
required for morphotypic multidrug resistance [14]. In
the current study, the recombinant M. smegmatis cells
were observed to increase in length. This is most likely
due to the changes of the mycobacterial cell wall, which
would contribute to mycobacterial sensitivity to anti-TB
drugs. All evidence makes MtrA a good target candidate
for drug design.
Conclusions
The two-component systems of M. tuberculosis are appar-
ently required for its growth and resistance in hostile host
environments, in which MtrAB has been reported to regu-
late the expression of the M. tuberculosis replication initia-
tor gene, dnaA. In the current study, we have identified
the conserved sites for the recognition of MtrA in the
dnaA promoter as well as approximately 420 potential
target genes. Further in vivo studies about a related organ-
ism, M. smegmatis, reveal changes in both cell morphology
and drug resistance when MtrA gene expression is inhib-
ited. The data presented here significantly enhance our
understanding of the regulatory mechanisms of the essen-
tial two-component MtrAB system and its role in the drug
resistance of M. smegmatis.
Methods
Cloning, expression and purification of recombinant
proteins
All DNA primers (Additional file 7) and oligonucleo-
tides (Additional file 8) were synthesized by Invitrogen.
M. tuberculosis mtrA was amplified using primers from
genomic DNA. The MtrA genes were cloned into the
overexpression vectors pET28a or pGEX-4T-1 to pro-
duce recombinant plasmids (Additional file 1). E. coli
BL21(DE3) cells that were transformed with the recom-
binant plasmid were grown at 37°C in 1 L of LB med-
ium containing 30 μg/mL kanamycin or 100 μg/mL
ampicillin, respectively. Protein purification was carried
out as described in earlier reports [21-24].
Bacterial one-hybrid analysis
The interaction between the regulatory region of the
M. tuberculosis dnaA gene and MtrA was assayed using
the bacterial one-hybrid technique [24]. The reporter vec-
tor pBXcmT and pTRG vectors containing MtrA were
generated (Additional file 1). The bacterial one-hybrid
assays were carried out as described in a previous study
[24]. Positive growth co-transformants were selected on
the screening medium plate containing 15 mM 3-AT,
8 μg/ml streptomycin, 15 μg/ml tetracycline, 34 μg/ml
chloramphenicol, and 50 μg/ml kanamycin.
Electrophoretic Mobility Shift Assay (EMSA)
The double-stranded substrates were prepared according
to a previously published procedure [21]. DNA-binding
assays of M. tuberculosis MtrA and its mutant proteins
were performed using a modified electrophoretic mobi-
lity shift assay (EMSA), as previously described [21-23]
but with several changes. The reactions (10 μL) for mea-
suring the mobility shift contained 200 fmol
32P-labeled
DNA and various amounts of MtrA diluted in a buffer
containing 20 mM Tris-HCl (pH 7.5), 100 mM NaCl,
0.5 mM MgCl2,1 0μg/ml sonicated salmon sperm
DNA, 0.7 mM 2-mercaptoethanol and 5% glycerol.
Reactions were performed and gels were exposed to a
storage-phosphor screen overnight at room temperature.
The images were acquired using a Typhoon scanner
(GE Healthcare).
Surface Plasmon Resonance (SPR) analysis
The interaction between the regulatory region of the
M. tuberculosis dnaA gene was assayed using SPR.
Biotin-labeled promoter DNA was immobilized onto a
SA chip (BIAcore), based on a previously published pro-
cedure [24]. The purified MtrA protein was passed over
the chip. DNA-protein interaction assays were performed
at 25°C. Each analysis was performed in triplicate. An
overlay plot was generated to illustrate the interactions.
Scanning Electron Microscopy (SEM) observation
M. smegmatis cells prepared for scanning electron micro-
scopy (SEM) observation were grown in LB for 24 hours
in the presence of 20 ng·mL
-1 tetracycline. Cells were
harvested by centrifugation. The bacterial pellets were
resuspended and incubated at 4°C for 24 hours in 2.5%
glutardialdehyde solution. The cells were washed twice in
double distilled water and then dehydrated by 15 min
treatments in 30, 50, 75, 85, 95 and 100% ethanol. The
incubation in 100% ethanol was repeated to ensure com-
plete dehydration. Samples were critical-point dried,
sputter-coated with gold, and observed using a scanning
electron microscope (S570; Hitachi, Tokyo, Japan).
Representative images are shown.
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For real-time PCR analysis, gene-specific primers (Addi-
tional file 9) were used and first-strand cDNAs were
synthesized using SuperScript II reverse transcriptase
(Invitrogen), according to the manufacturer’si n s t r u c -
tions. Each PCR reaction (10 μl) contained 10 μlo f2 ×
SYBR Green Master Mix Reagent (Applied Biosystems),
1.0 μl of cDNA samples, and 200 nM gene-specific pri-
mers. The thermocycling conditions were 95°C for
5 min, and 40 cycles at 95°C for 30 s, 60°C for 30 s and
72°C for 30 s. Amplification specificity was assessed
using melting curve analysis. Different gene expressions
were normalized to the levels of 16S rRNA gene tran-
scripts [15]. The degrees of expression change were
calculated using the 2
-ΔΔCt method [25].
Drug resistance assays
The antimicrobial activity of four first-line anti-tuberculosis
drugs against M. smegmatis was determined using a modi-
fied bacterial growth time course assay. M. smegmatis was
g r o w ni nL Ba t3 7 ° Co v e r n i g h t .T h i sc u l t u r ew a st h e n
diluted (1:100) in 5 ml of fresh LB broth containing the
indicated concentration of each drug, and the culture was
again incubated at 37°C with shaking at 220 rpm for two
days. Samples were taken at various time points (0, 6, 12,
18, 24, 30, 36, 42, and 48 h). Optical density was measured
at 600 nm (OD600) using a Beckman DU650 spectrophot-
ometer. All assays were performed three times. Representa-
tive growth curves are shown.
DNase I footprinting assays
The 84 bp (S6) and 75 bp (S7) dnaA promoter regions
were amplified (dnaAf1 and dnaAr2 were used to
amplify S6 from genomic DNA, while dnaAf3 and
dnaAr4 were used to amplify S7) (Additional file 7) and
cleaved by endonuclease EcoRI, leaving a sticky 5’ end
that was five nucleotides from the original end. The
recessive 3’ e n dw a sl a b e l e dw i t h[ a-
32P] dATP (Furui
Biotech, Beijing, China) by the Klenow fragment, and
then subjected to the same binding reaction as in the
electrophoretic mobility shift assay. DNase I footprinting
was performed as previously described [26]. The ladders
were produced using the Sanger dideoxy method and
dnaAf1 and dnaAf3 primers that were end-labeled by
T4 polynucleotide kinase and [g-
32P ]A T P( F u r u iB i o -
tech, Beijing, China), respectively.
Bioinformatics assays on the distribution of the identified
7 bp motif within mycobacterial genomes
The regulatory sequences were collected from the com-
plete genomes of M. tuberculosis and M. smegmatis and
the database of intergenic regions of ORFs (from stop
codon to start codon) were constructed. The exact
motifs (CACGCCG or CACGAGG) were then used to
search for the distribution of the identified 7 bp motifs
in the M. tuberculosis H37Rv and the M. smegmatis
genomes. The identified target genes are listed (Addi-
tional file 10 and Additional file 11).
Additional material
Additional file 1: Plasmids and recombinant vectors used in this
study. The data present plasmids and recombinant vectors used in this
study.
Additional file 2: SPR assays for the binding of unspecific promoter
chip by MtrA. The data present SPR assays for the binding of unspecific
promoter chip by MtrA.
Additional file 3: Competing SPR assay with the unlabeled DNA
fragments for the binding of the promoter chip by MtrA. The data
present the competing SPR assay with the unlabeled DNA fragments for
the binding of the promoter chip by MtrA.
Additional file 4: Potential target genes for MtrA in M. tuberculosis.
The data provided potential target genes for MtrA in M. tuberculosis.
Additional file 5: Potential target genes for MtrA in M.smegmatis.
The data present Potential target genes for MtrA in M.smegmatis.
Additional file 6: Homologous target genes recognized by MtrA in
M. tuberculosis and M. smegmatis. The data present homologous
target genes recognized by MtrA in M. tuberculosis and M. smegmatis.
Additional file 7: Primers used in this study. The data provided
primers used in this study.
Additional file 8: Sequences of the DNA substrates used in this
study. The data provided sequences of the DNA substrates used in this
study.
Additional file 9: Primers used for quantitative real time PCR in this
study. The data present the primers used for quantitative real time PCR
in this study.
Additional file 10: Classification and percentage of the target genes
containing the 7-bp motif recognized by MtrA in M. smegmatis.T h e
data present the categories and percentage of the target genes
containing the 7-bp motif recognized by MtrA in M. smegmatis.
Additional file 11: The data present the categories and percentage
of the target genes containing the 7-bp motif recognized by MtrA
in M. tuberculosis. The data present the categories and percentage of
the target genes containing the 7-bp motif recognized by MtrA in
M. tuberculosis.
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